Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224419 · ClinicalTrials.gov registry record · Phase 4
Testing Pharmacological Therapies for Pregnant Smokers
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
NCT00224419 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 181 participants.
The verdict
NCT00224419, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
Study Summary
Nicotine dependence has not been sufficiently addressed in current state-of-the-science cessation interventions for pregnant smokers. The weight of the evidence from the general population of smokers suggests that nicotine replacement therapies may be beneficial cessation aids for pregnant smokers who are unable to stop smoking. The tremendous potential of these therapies for promoting smoking cessation among pregnant women creates a pressing need for decision tools and protocols to encourage treatment adherence that is essential for rigorous evaluation of the effectiveness of OTC NRT when provided as part of prenatal care. The results of this research could be directly translated to the improvement of obstetrical care providers' clinical practices. Medically supervised use of OTC NRT by pregnant smokers is an alternative to continued smoking that has the potential to substantially increase rates of smoking cessation during pregnancy.
Interventions
- BEHAVIORAL Motivational interviewing for smoking cessation
- BEHAVIORAL Cognitive behaviors therapy
- DRUG CBT + NRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2003-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00224419
The ClinicalTrials.gov registry entry for NCT00224419 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Motivational interviewing for smoking cessation is the first listed.
NCT00224419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00224419 about?
NCT00224419 is a clinical study titled "Testing Pharmacological Therapies for Pregnant Smokers". Nicotine dependence has not been sufficiently addressed in current state-of-the-science cessation interventions for pregnant smokers. The weight of the evidence from the general population of smokers suggests that nicotine replacement therapies may be beneficial cessation aids for pregnant smokers w...
What is the current status of trial NCT00224419?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2003-06.
What interventions are being tested in trial NCT00224419?
The interventions under investigation include: Motivational interviewing for smoking cessation (BEHAVIORAL), Cognitive behaviors therapy (BEHAVIORAL), CBT + NRT (DRUG).
Who is sponsoring clinical trial NCT00224419?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.